RE: Can someone let the Twiterati know the below.17 Dec 2024 11:06
Thorn
I used to like you. What is your point?
It was one of CC’s favourite slides at the beginning of the year where the graph shows that the level of antitumour activity is not necessarily higher in high FAP tumours than it is in mid FAP tumours like TNBC.
She didn’t suddenly wake up one morning and think “some tumours in the trials so far aren’t responding too well, I know we’ll give TNBC patients a go. Like you seem to be implying.
Then when the breast clinic oncologist said “we can kill the tumours but many patients die from the collateral damage on their organs” coupled with the massive number of TNBC patients out there. That is wasn’t a hard choice to say let’s put a number of these into P1b. Also I would be very surprised if said breast clinic would be over the moon to supply patients or even run part of the trial.
All IMHO of course until I’ve run it past ChatGPT.